Explore more Johnson & Johnson sites:
Learn More About Janssen's Phase 3 COVID-19 Vaccine Candidate Clinical Trials Here
Learn More
Photos, Videos & Infographics
August 25, 2017
Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD) affect 16.5 million and 10 million Americans, respectively. Learn more about CAD and PAD and whether you could be at risk.
Media Center
October 14, 2016
We’re proud to be named to the Best Companies for Working Moms list by Working Mother magazine. But why were we? Hear the real scoop from 10 Johnson & Johnson working moms!
More From J&J
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
The heart condition affects up to six million Americans, and raises the risk of stroke five-fold. One patient describes what it was like to learn she had atrial fibrillation—and the unexpected positive impact it has had on her life.
Njira Lugogo, M.D., is a pulmonologist at the University of Michigan who is leading a clinical study of an investigational COVID-19 vaccine candidate. She helps answer common questions people may have about the process, from what people over 60 need to know to how participants are being kept safe during the pandemic.
